247 related articles for article (PubMed ID: 33061567)
1. miR-133a-3p Regulates Hepatocellular Carcinoma Progression Through Targeting CORO1C.
Han S; Ding X; Wang S; Xu L; Li W; Sun W
Cancer Manag Res; 2020; 12():8685-8693. PubMed ID: 33061567
[TBL] [Abstract][Full Text] [Related]
2. miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma.
Yin Y; Du L; Li X; Zhang X; Gao Y
J Cell Physiol; 2019 Aug; 234(8):12757-12770. PubMed ID: 30537034
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.
Wang G; Zhu S; Gu Y; Chen Q; Liu X; Fu H
Dig Dis Sci; 2015 Oct; 60(10):3044-52. PubMed ID: 26173501
[TBL] [Abstract][Full Text] [Related]
4. Hsa_circ_0016788 regulates hepatocellular carcinoma progression via miR-506-3p/poly-adenosine diphosphate-ribose polymerase.
Chen M; Hu G; Zhou X; Peng Z; Wen W
J Gastroenterol Hepatol; 2021 Dec; 36(12):3457-3468. PubMed ID: 34340259
[TBL] [Abstract][Full Text] [Related]
5. MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1.
He B; Lin X; Tian F; Yu W; Qiao B
J Cell Biochem; 2018 Jan; 119(1):338-346. PubMed ID: 28569392
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma.
Zhang W; Liu K; Liu S; Ji B; Wang Y; Liu Y
Tumour Biol; 2015 Dec; 36(12):9779-88. PubMed ID: 26156803
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
Zhao X; Chen GQ; Cao GM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488
[TBL] [Abstract][Full Text] [Related]
8. C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.
Li H; Zhang B; Ding M; Lu S; Zhou H; Sun D; Wu G; Gan X
Hepatol Int; 2019 May; 13(3):277-292. PubMed ID: 31069760
[TBL] [Abstract][Full Text] [Related]
9. MiR-133a-3p inhibits the malignant progression of oesophageal cancer by targeting CDCA8.
Wang X; Zhu L; Lin X; Huang Y; Lin Z
J Biochem; 2022 Jan; 170(6):689-698. PubMed ID: 34117764
[TBL] [Abstract][Full Text] [Related]
10. EZH2-mediated lncRNA ABHD11-AS1 promoter regulates the progression of ovarian cancer by targeting miR-133a-3p.
Zhang W; Huang X; Shi J
Anticancer Drugs; 2021 Mar; 32(3):269-277. PubMed ID: 33491971
[TBL] [Abstract][Full Text] [Related]
11.
He L; Xu K; Niu L; Lin L
Pharm Biol; 2022 Dec; 60(1):1710-1720. PubMed ID: 36086826
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA Ameliorates Progression of CAD Through Regulating Cardiac H9c2 Cells Proliferation and Apoptosis by miR-133a-3p/EGFR Axis.
Xu H; Li H; Zhu P; Liu Y; Zhou M; Chen A
Drug Des Devel Ther; 2020; 14():2853-2863. PubMed ID: 32764884
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-133a-3p inhibits cell proliferation, migration and invasion in colorectal cancer by targeting AQP1.
Kong B; Zhao S; Kang X; Wang B
Oncol Lett; 2021 Sep; 22(3):649. PubMed ID: 34386071
[TBL] [Abstract][Full Text] [Related]
15. Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis.
Liu Y; Liu J; Cui J; Zhong R; Sun G
Bioengineered; 2022 Jan; 13(1):1115-1125. PubMed ID: 34978464
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
Liu Z; Ouyang G; Lu W; Zhang H
Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
[TBL] [Abstract][Full Text] [Related]
17. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.
Dang S; Zhou J; Wang Z; Wang K; Dai S; He S
Biomed Pharmacother; 2018 Oct; 106():966-975. PubMed ID: 30170358
[TBL] [Abstract][Full Text] [Related]
18. miR-1249-3p accelerates the malignancy phenotype of hepatocellular carcinoma by directly targeting HNRNPK.
Shu H; Hu J; Deng H
Mol Genet Genomic Med; 2019 Oct; 7(10):e00867. PubMed ID: 31429522
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA deleted in lymphocytic leukaemia 1 promotes hepatocellular carcinoma progression by sponging miR-133a to regulate IGF-1R expression.
Zhang W; Liu S; Liu K; Liu Y
J Cell Mol Med; 2019 Aug; 23(8):5154-5164. PubMed ID: 31207081
[TBL] [Abstract][Full Text] [Related]
20. RP11-295G20.2 facilitates hepatocellular carcinoma progression via the miR-6884-3p/CCNB1 pathway.
Li J; Xia T; Cao J; He D; Chen Z; Liang B; Song J
Aging (Albany NY); 2020 Jul; 12(14):14918-14932. PubMed ID: 32687483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
